The United Kingdom stockpile of Relenza is complete and amounts to 10.5 million treatment courses. Approximately 300,000 treatment courses have been distributed to the national health service in England.
The delivery profile as indicated by the manufacturer should lead to us completing the stockpile in October 2009.